SciBase Announces the Launch of EBarrier Score, the First AI-Driven Skin Barrier Assessment Tool for Research and Cosmetic Testing
SciBase Announces the Launch of EBarrier Score, the First AI-Driven Skin Barrier Assessment Tool for Research and Cosmetic Testing
STOCKHOLM, May 29, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin disorders is pleased to announce the launch of the eBarrier Score for Nevisense, the first-ever AI skin barrier assessment tool built for use in research and cosmetic testing. The eBarrier Score was announced today at the Cosmetotest cosmetic testing symposium in Lyon, France.
2024年5月29日，斯德哥爾摩/美通社——皮膚科技公司SciBase Holding AB（以下簡稱“SciBase”）（斯德哥爾摩證券交易所：SCIB）是一家領先的基於人工智能（AI）的解決方案開發公司，專注於皮膚疾病。SciBase非常榮幸地宣佈推出Nevisense的eBarrier Score，這是全球首個專爲研究和化妝品測試而構建的人工智能皮膚屏障評估工具。eBarrier Score今天在法國里昂舉行的Cosmetotest化妝品測試研討會上宣佈。
Researchers of the skin barrier and cosmetic products can now use Nevisense and the eBarrier Score to assess products and claims related to skin barrier function. The global market for cosmetic products aiming to improve people's skin barrier is experiencing immense growth.
皮膚屏障和化妝品產品的研究人員現在可以使用Nevisense和eBarrier Score來評估與皮膚屏障功能相關的產品和聲明。旨在改善人們皮膚屏障的化妝品產品全球市場正經歷着巨大增長。
Nevisense and the eBarrier Score utilize AI-generated algorithms that researchers can use to directly quantitate the severity of skin barrier dysfunction related to common skin disorders.
Nevisense和eBarrier Score利用由人工智能生成的算法，研究人員可以直接量化與常見皮膚疾病相關的皮膚屏障功能嚴重程度。
In a recently published study (Skin Barrier Function Assessment: Electrical Impedance Spectroscopy Is Less Influenced by Daily Routine Activities Than Transepidermal Water Loss - the first direct comparison between electrical impedance spectroscopy (EIS) using Nevisense and trans-epidermal water loss (TEWL) was made. The study demonstrates Nevisense being a more robust technique to assess skin barrier function than the within research commonly used TEWL measurement technique.
在最近發表的研究中（皮膚屏障功能評估：電阻抗譜的受干擾程度低於經常使用的經皮水損失測量法——是電阻抗譜使用Nevisense和經皮水損失測量（TEWL）之間的首次直接比較。該研究證明了Nevisense比TEWL更穩健的技術來評估皮膚屏障功能，而後者常用於研究中。
"We are thrilled to introduce the eBarrier Score to the cosmetic research market," said Pia Renaudin, CEO of SciBase. "Every day, there are new cosmetic products related to skin barrier function. The Nevisense eBarrier Score is already an established tool in the medical research field and bringing it to the cosmetic research market will truly benefit consumers."
“我們很高興將eBarrier Score引入化妝品研究市場，”SciBase的首席執行官Pia Renaudin表示。“每天都有與皮膚屏障功能相關的新化妝品產品。Nevisense eBarrier Score已經成爲醫學研究領域的一個成熟工具，引入化妝品研究市場將真正惠及消費者。”
For more information on the eBarrier Score and SciBase's other research or medical products, visit scibase.com. In February SciBase announced a partnership with Skinobs, a leading global platform connecting researchers with the tools they need for their cosmetic and medical research. Through this partnership, SciBase can now offer Nevisense and eBarrier for assessing skin barrier function within cosmetic testing on the Skinobs platform.
有關eBarrier Score和SciBase的其他研究或醫療產品的更多信息，請訪問scibase.com。今年2月，SciBase宣佈與Skinobs達成合作夥伴關係，Skinobs是一家領先的全球平台，將研究人員與他們在化妝品和醫療研究中所需的工具連接起來。通過這種合作，SciBase現在可以在Skinobs平台上爲Nevisense和eBarrier提供在化妝品測試中評估皮膚屏障功能的服務。
For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]
Certified Advisor (CA):
Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]
欲了解更多信息，請聯繫:
Pia Renaudin，VD，電話+46 732069802，電子郵件：[email protected]
認證顧問（CA）：
Vator Securities
電話：+46858006599
電子郵件：[email protected]
About SciBase:
關於SciBase：
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
SciBase是一家全球性醫療技術公司，專注於皮膚疾病的早期檢測和預防。SciBase開發和商業化Nevisense，這是一種獨特的點對點平台，結合了人工智能和先進的電阻抗譜技術，提高了診斷準確性，確保積極的皮膚健康管理。
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
我們致力於減少患者的痛苦，使臨床醫生通過及時檢測和干預來改善和挽救生命，並降低醫療保健成本。
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
SciBase在瑞典斯德哥爾摩的卡羅林斯卡學院進行了20多年的研究，是皮膚病學進展的領先者。
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:
該公司自2015年6月2日在納斯達克創業板上市。請訪問了解更多信息。所有新聞發佈和財務報告都可以在此找到：
This information was brought to you by Cision
本信息由Cision提供
The following files are available for download:
以下文件可供下載：
|
eBarrier Score PR |
|
eBarrier Score新聞稿 |
譯文內容由第三人軟體翻譯。